metyrapone has been researched along with Vitiligo in 3 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolecek, R | 3 |
3 other studies available for metyrapone and Vitiligo
| Article | Year |
|---|---|
[Metyrapone in the therapy of vitiligo].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Metyrapone; Middle Aged; Vitiligo | 1983 |
Treatment of vitiligo.
Topics: Adrenocorticotropic Hormone; Humans; Metyrapone; Pigmentation; Vitiligo | 1968 |
[Administration of metopirone in the treatment of vitiligo].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Metyrapone; Middle Aged; Vitiligo | 1968 |